Sterile Processing Failure Discovered After the Fact
A sterile processing technician reports that a load of orthopedic instrument sets was released after a cycle in which the biological indicator was incubated but read at 18 hours instead of the manufacturer's required 24 hours. The load was used in three orthopedic cases the following morning. The sets included power equipment and cannulated drills. The sterilizer is a pre-vacuum steam unit that passed its last three biological indicator tests. The facility uses a 24-hour read for the biological indicator. The IP is asked to determine whether the patients are at risk and what actions are needed.
1. What is the significance of the early-read biological indicator, and how should the IP assess risk to the three patients?
Read the worked answer
The biological indicator is the accepted monitor of sterilization efficacy; reading it before the required incubation period means the result is not valid and the load should not have been released. The risk to patients depends on whether the load was actually sterile, which cannot be assumed.
The IP should assess risk by: confirming the sterilizer's physical parameters for that cycle (temperature, pressure, exposure time) if recorded; reviewing the sterilizer's maintenance and qualification history; confirming that chemical indicators in the load changed appropriately; and determining whether the early read was a one-time lapse or part of a pattern. The IP should also consider the instruments involved: cannulated drills and power equipment are complex, and their reprocessing requires validated methods.
The patients are at some nonzero risk, but the magnitude is uncertain. The IP should not reassure based on the early read alone; the correct posture is to investigate the cycle and the process, and to involve clinical leadership in deciding whether patient notification or surveillance is warranted.
2. What immediate actions should be taken regarding the sterilizer, the instruments, and the patients?
Read the worked answer
Sterilizer: quarantine the unit from use until the cause is understood and the unit is requalified (e.g., repeat biological indicator with full incubation, physical parameter review, maintenance check). Review whether other loads were affected by the same practice.
Instruments: recall any remaining instruments from the load if possible; if they were used, they cannot be recalled, but the sets should be reprocessed before reuse. Review the load records to identify exactly which sets and which patients.
Patients: the IP should work with surgery and infectious disease to determine whether surveillance or notification is appropriate. Given the uncertainty, a conservative approach - informing the clinical team, monitoring for signs of infection, and documenting - is reasonable. Notification of patients should be considered if the risk is judged material; the decision should be made with risk management and documented.
Process: the IP should review why the early read occurred (staffing, training, workflow, manufacturer instructions) and correct the practice.
3. What system changes should the IP recommend to prevent recurrence?
Read the worked answer
The IP should recommend: (1) a clear policy that loads are not released until the biological indicator is read per manufacturer instructions, with a process for handling read-time deviations; (2) training and competency assessment for sterile processing staff on incubation and read times; (3) a mechanism to flag and hold loads when a monitor is read early or is otherwise invalid; (4) review of the sterilizer's monitoring records and maintenance schedule; and (5) consideration of rapid-read biological indicators if the facility's workflow makes 24-hour holds impractical, with validation.
The IP should also recommend auditing release practices and documenting the event in the quality system, with follow-up to confirm the changes are effective. The broader lesson is that the sterile processing workflow must be designed so that the correct action is the easy action.